References
- Al-Hajj M , WichaMS , Benito-HernandezA , MorrisonSJ , ClarkeMF . Prospective identification of tumorigenic breast cancer cell . Proc. Natl Acad. Sci. USA100 ( 7 ), 3983 – 3988 ( 2003 ).
- Kondo T , SetoguchiT , TagaT . Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line . Proc. Natl Acad. Sci. USA101 ( 3 ), 781 – 786 ( 2004 ).
- Singh SK , HawkinsC , ClarkeIDet al. Identification of human brain tumour initiating cells . Nature432 ( 7015 ), 396 – 401 ( 2004 ).
- Huntly BJP , GillilandDG . Leukaemia stem cell and the evolution of cancer-stem-cell research . Nat Rev. Cancer5 ( 4 ), 311 – 321 ( 2005 ).
- Kim CFB , JacksonEL , WoolfenderAEet al. Identification of bronchioalveolar stem cells in normal lung and lung cancer . Cell121 ( 6 ), 823 – 835 ( 2005 ).
- ElHelou R , WicinskiJ , GuilleAet al. A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome . Stem Cells. doi:10.1002/stem.1792 ( 2014 ) ( Epub ahead of print ).
- Oshima N , YamadaY , NagayamaSet al. Induction of cancer stem cell properties in colon cancer cells by defined factors . PLoS ONE.9 ( 7 ), e101735 ( 2014 ).
- Seery JP , WattFM . Asymmetric stem-cell divisions define the architecture of human oesophageal epithelium . Curr. Biol.10 ( 22 ), 1447 – 1450 ( 2000 ).
- Seery JP . Stem cell of the oesophageal epithelium . J. Cell Sci.115 ( Pt 9 ), 1783 – 1789 ( 2002 ).
- Ando N , KatoH , IgakiHet al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907) . Ann. Surg. Oncol.19 ( 1 ), 868 – 874 ( 2012 ).
- Laffin B , WellbergE , KwakHIet al. Loss of singleminded-2s in the mouse mammary gland induces an epithelial-mesenchymal transition associated with up-regulation of slug and matrix metalloprotease 2 . Mol. Cell Biol.28 ( 6 ), 1936 – 1946 ( 2008 ).
- Boumber Y , IssaJP . Epigenetics in cancer: what’s the future?Oncology25 ( 3 ), 220 – 226 ( 2011 ).
- Ono H , ImotoI , KozakiKet al. SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation . Oncogene31 ( 47 ), 4923 – 4934 ( 2012 ).
- Micalizzi D , ChristensenK . Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-β . J. Clin. Invest.119 ( 9 ), 2678 – 2690 ( 2009 ).
- Micalizzi DS , WangC-A , FarabaughSM , SchiemannWP , FordHL . Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth . Cancer Res.70 ( 24 ), 10371 – 10380 ( 2010 ).
- Farabaugh SM , MicalizziDS , JedlickaP , ZhaoR , FordHL . Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties . Oncogene1 ( 5 ), 552 – 562 ( 2012 ).
- Ng KT , ManK , SunCKet al. Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma . Br. J. Cancer95 ( 8 ), 1050 – 1055 ( 2006 ).
- Micalizzi DS , WangCA , FarabaughSM , SchiemannWP , FordHL . Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival . Cancer Res.67 ( 7 ), 3036 – 3042 ( 2007 ).
- Shen H , FridleyBL , SongHet al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer . Nat. Commun. doi:10.1038/ncomms2629. ( 2013 ) ( Epub ahead of print ).